4SC
4SC AG is a German biotech company that no longer has any operating business of its own and is being delisted from the Frankfurt Stock Exchange.
Last updated September 15, 2026
AI crawler reads
No AI crawler has read this profile since Oct 28, 2026.
Overview
4SC AG is a German biotech company. According to its own website, following a negative opinion issued by the European Medicine Agency on Resminostat, efforts to further develop and commercialize the drug were discontinued, and the company no longer has any operating business of its own. It states that it currently has no products under development and no operational business, and that no clinical studies are currently being conducted. 4SC has out-licensed and partnered drug candidates to several national and international pharma and biotech companies. In December 2025, 4SC AG announced that a capital reduction to zero and simultaneous capital increase became effective, along with delisting from the Frankfurt Stock Exchange.
History
4SC AG is a German biotech company. Following a negative opinion issued by the European Medicine Agency on Resminostat, efforts to further develop and commercialize the drug were discontinued, and the company no longer has any operating business of its own. The company states that it currently has no products under development and no operational business, and that no clinical studies are currently being conducted. 4SC has out-licensed and partnered drug candidates to several national and international pharma and biotech companies. In November and December 2025, 4SC AG announced capital measures resolved by the 2025 AGM, including a capital reduction to zero and simultaneous capital increase, expected to lead to the expiry of all old shares and delisting from the Frankfurt Stock Exchange.
Products and positioning
Resminostat
Domatinostat
Sources5 sources
Cite this profile: Cite the canonical profile. /brand-wiki/4sc · Editorial policy · How profiles are compiled